Buscar resultados de ensayos clínicos
Coma - 982 Studies Found
Estado | Estudiar |
Not yet recruiting |
Nombre del estudio: Medroxyprogesterone Acetate With or Without Entinostat Before Surgery in Treating Patients With Endometrioid Endometrial Cancer Condición:
|
Recruiting |
Nombre del estudio: Paclitaxel Albumin-Stabilized Nanoparticle Formulation and Bevacizumab in Treating Patients With Stage IV Melanoma That Cannot Be Removed by Surgery or Gynecological Cancers Condición:
Intervenciones: |
Completed |
Nombre del estudio: Study of PXD101 Alone and in Combination With 5-Fluorouracil (5-FU) in Patients With Advanced Solid Tumors Condición: Tumor Fecha: 2006-12-18 Intervenciones:
|
Completed |
Nombre del estudio: Study of Oral PXD101 in Patients With Advanced Solid Tumors or Lymphoma Condición:
Fecha: 2006-12-18 Intervenciones: Drug: oral belinostat oral belinostat dosed once or twice daily at continuous and discontinuous dosing s |
Terminated |
Nombre del estudio: Pazopanib for Metastatic Alveolar Soft Part Sarcoma Condición: Metastatic Alveolar Soft Part Sarcoma Fecha: 2014-04-09 Intervenciones: Drug: Pazopanib Pazopanib 800mg qd daily for 4 weeks = 1 cycle |
Recruiting |
Nombre del estudio: A Phase 2 Study of Anti-PD-L1 Antibody Atezolizumab in Alveolar Soft Part Sarcoma Condición: Alveolar Soft Part Sarcoma Fecha: 2017-05-03 Intervenciones: Drug: Atezolizumab Atezolizumab is a human monoclonal antibody directed against programmed death-ligand |
Active, not recruiting |
Nombre del estudio: A Trial of Cediranib in the Treatment of Patients With Alveolar Soft Part Sarcoma (CASPS) Condición: Alveolar Soft-part Sarcoma Fecha: 2011-04-11 Intervenciones:
|
Recruiting |
Nombre del estudio: Axitinib and Pembrolizumab in Subjects With Advanced Alveolar Soft Part Sarcoma and Other Soft Tissue Sarcomas Condición:
Fecha: 2015-12-14 Intervenciones:
|
Completed |
Nombre del estudio: Collection of Alveolar Soft Part Sarcoma and Blood Specimens for Research Condición:
Fecha: 2006-06-19 |
Not yet recruiting |
Nombre del estudio: A Phase III Trial of Anlotinib in Metastatic or Advanced Alveolar Soft Part Sarcoma, Leiomyosarcoma and Synovial Sarcoma Condición:
|